Tianjin Pharmaceutical Da Ren Tang Co., Ltd. (600329)
Market Open
11 Aug, 06:57
SSE SSE Primary 
SGX ¥
37. 35
+0.14
+0.3762%
¥
22.62B Market Cap
- P/E Ratio
0.6% Div Yield
777,500 Volume
- Eps
¥ 37.21
Previous Close Want to track 600329 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tianjin Pharmaceutical Da Ren Tang Co., Ltd. (600329) Statistics
Valuation metrics
Market Cap 22.62B
Enterprise value 20.35B
Trailing P/E (ttm) 13.13
Forward P/E -
PEG ratio -7.56
Price/Sales (ttm) 4.26
Price/Book (mrq) 3.81
Enterprise Value/Revenue 4.09
Enterprise Value/EBITDA 18.96
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.46M
Average volume (90 days) 4.31M
Price summary
52-Week low 34.7
52-Week high 50.97
Beta -
50-Day moving average 38.07
200-Day moving average 40.87
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.34
Trailing annual dividend yield 0.0629%
5-Year annual dividend yield -
Payout ratio 0.86
Dividend Date 10 Jul 2026
Ex-Dividend Date 10 Jul 2026
Last split factor 2:1
Last split Date 5 Jul 2010
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.44%
Operating margin 0.49%
Operational effectiveness
Return on assets 0.21%
Return on equity 0.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 6.46
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.3
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 2.16%
Book value per share (mrq) 9.77
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
